FFM
ACHN

Fairmount Funds Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Fairmount Funds Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-624,956
Closed -$3.77M – 18
2019
Q4 		$3.77M Buy
+624,956
New +$3.62M 2.28% 12

Fairmount Funds Management's ACHN Position: Q1 2020 in Review

Fairmount Funds Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 624,956 shares — an estimated $3.77M sold.

Fairmount Funds Management first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $3.77M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Fairmount Funds Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Fairmount Funds Management sold 624,956 Achillion Pharmaceuticals shares in Q1 2020, an estimated $3.77M.
  • Fairmount Funds Management first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Fairmount Funds Management's Achillion Pharmaceuticals position peaked at $3.77M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Fairmount Funds Management's 13F filing for Q1 2020, filed 8 May 2020.